Mozaffari Shilan, Esmaily Hadi, Rahimi Roja, Baeeri Maryam, Sanei Yara, Asadi-Shahmirzadi Azar, Salehi-Surmaghi Mohammad-Hossein, Abdollahi Mohammad
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Pharmacogn Mag. 2011 Jul;7(27):213-23. doi: 10.4103/0973-1296.84235.
In irritable bowel syndrome (IBS), disturbance of bowel motility is associated with infiltration of inflammatory mediators and cytokines into the intestine, such as neutrophils, myeloperoxidase (MPO), tumor necrosis factor alfa (TNF-α), and lipid peroxide.
Regarding promising anti-inflammatory and anti-oxidative effects of Hypericum perforatum (HP) extract, besides its anti-depressant effect, this study was designed to evaluate the effects of HP in an experimental model of IBS.
IBS was induced by a 5-day restraint stress in rats. The HP extract was administered by gavage in doses of 150, 300, and 450 mg/kg for 26 days. Fluoxetine and loperamide were used as positive controls. Gastric emptying and small bowel and colon transit, besides the levels of TNF-α, MPO, lipid peroxidation, and antioxidant power, were determined in colon homogenates.
Data were analyzed by one-way ANOVA followed by Tukey's post hoc test for multiple comparisons.
A significant reduction in small bowel and colonic transit (450 mg/kg), TNF-α, MPO, and lipid peroxidation and an increase in antioxidant power in all HP-treated groups (150, 300, and 450 mg/kg) were seen as compared with the control group. Gastric emptying did not alter significantly when compared with the control group. Treatment with loperamide (10 mg/kg) significantly inhibited gastric emptying and small bowel and colonic transit, while flouxetine (10 mg/kg) decreased gastric emptying, TNF-α, MPO, and lipid peroxidation and increased the antioxidant power of the samples in comparison with the control group.
HP diminished the recruitment of inflammatory cells and TNF-α following restraint stress not in a dose-dependent manner, possibly via inhibition of MPO activity and increasing colon antioxidant power, without any difference with fluoxetine. The HP extract inhibits small bowel and colonic transit acceleration like loperamide but has minimal effect on gastric emptying.
在肠易激综合征(IBS)中,肠道运动紊乱与炎症介质和细胞因子浸润肠道有关,如中性粒细胞、髓过氧化物酶(MPO)、肿瘤坏死因子α(TNF-α)和脂质过氧化物。
鉴于贯叶连翘(HP)提取物除具有抗抑郁作用外,还具有良好的抗炎和抗氧化作用,本研究旨在评估HP在IBS实验模型中的作用。
通过对大鼠进行为期5天的束缚应激诱导IBS。以150、300和450mg/kg的剂量通过灌胃给予HP提取物,持续26天。氟西汀和洛哌丁胺用作阳性对照。除了测定结肠匀浆中TNF-α、MPO、脂质过氧化和抗氧化能力的水平外,还测定了胃排空以及小肠和结肠转运情况。
数据通过单因素方差分析,随后进行Tukey事后检验以进行多重比较。
与对照组相比,所有HP治疗组(150、300和450mg/kg)的小肠和结肠转运(450mg/kg)、TNF-α、MPO和脂质过氧化均显著降低,抗氧化能力增加。与对照组相比,胃排空无显著变化。与对照组相比,洛哌丁胺(10mg/kg)治疗显著抑制胃排空以及小肠和结肠转运,而氟西汀(10mg/kg)降低胃排空、TNF-α、MPO和脂质过氧化,并增加样本的抗氧化能力。
HP可能通过抑制MPO活性和增加结肠抗氧化能力,以非剂量依赖方式减少束缚应激后炎症细胞和TNF-α的募集,与氟西汀无差异。HP提取物像洛哌丁胺一样抑制小肠和结肠转运加速,但对胃排空影响最小。